Clinical trials
Observational Pancreatic Neoplasms trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
159 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 7 |
| 2014 | 3 |
| 2015 | 8 |
| 2016 | 8 |
| 2017 | 8 |
| 2018 | 13 |
| 2019 | 18 |
| 2020 | 12 |
| 2021 | 18 |
| 2022 | 21 |
| 2023 | 11 |
| 2024 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 159 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking Union Medical College Hospital | 7 |
| Assiut University | 4 |
| Changhai Hospital | 4 |
| Seoul National University Hospital | 4 |
| Azienda Ospedaliera Universitaria Integrata Verona | 3 |
| Massimo Falconi | 3 |
| National Taiwan University Hospital | 3 |
| RenJi Hospital | 3 |
| Royal Marsden NHS Foundation Trust | 3 |
| Ruijin Hospital | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 159 |
| Stomach Neoplasms | 18 |
| Colorectal Neoplasms | 14 |
| Breast Neoplasms | 13 |
| Esophageal Neoplasms | 13 |
| Cholangiocarcinoma | 12 |
| Liver Neoplasms | 12 |
| Lung Neoplasms | 10 |
| Ovarian Neoplasms | 10 |
| Neoplasms | 8 |
Trials
Showing 1 to 25 of 159. Each trial links to its page on Pharma Observatory.
59 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.